Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis

The objective of the study: to assess the efficiency of therapeutic discrete automated plasmapheresis in the management of hepatotoxic reactions, developed in tuberculosis patients with multiple and extensive drug resistance, including those with concurrent viral hepatitis.Subjects and methods. 136...

Full description

Bibliographic Details
Main Authors: E. V. Vаniev, A. G. Sаmoylovа, A. E. Ergeshov, O. V. Lovаchevа, I. A. Vаsilyevа
Format: Article
Language:Russian
Published: New Terra Publishing House 2018-11-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1180
_version_ 1797700224912719872
author E. V. Vаniev
A. G. Sаmoylovа
A. E. Ergeshov
O. V. Lovаchevа
I. A. Vаsilyevа
author_facet E. V. Vаniev
A. G. Sаmoylovа
A. E. Ergeshov
O. V. Lovаchevа
I. A. Vаsilyevа
author_sort E. V. Vаniev
collection DOAJ
description The objective of the study: to assess the efficiency of therapeutic discrete automated plasmapheresis in the management of hepatotoxic reactions, developed in tuberculosis patients with multiple and extensive drug resistance, including those with concurrent viral hepatitis.Subjects and methods. 136 patients suffering from respiratory tuberculosis with multiple and extensive drug resistance were enrolled in the study. 56 of them had viral hepatitis: 3 (5.4%) patients suffered from hepatitis B, 49 (87.5%) from hepatitis С and 4 (7.1%) had both hepatitis В + С. After the initiation of chemotherapy, out of 56 patients with viral hepatitis, 36 (64.3%) developed hepatotoxic reactions which was statistically significantly more frequent versus 23 (28.8%) patients out of 80 ones without viral hepatitis, p < 0.01. Patients with hepatotoxic reactions were randomly divided into two groups (29 and 30 patients), and plasmapheresis was used to manage drug-induced liver disorders in one of them. Results. This method was used in 29 patients and it allowed managing hepatotoxic reactions without cancellation of chemotherapy. In the group where no plasmapheresis was used, chemotherapy was temporarily discontinued in 12 (40.0%) out of 30 patients from 6 to 20 days.
first_indexed 2024-03-12T04:19:10Z
format Article
id doaj.art-9573b86d5228410ca493bb5943454959
institution Directory Open Access Journal
issn 2075-1230
2542-1506
language Russian
last_indexed 2024-03-12T04:19:10Z
publishDate 2018-11-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj.art-9573b86d5228410ca493bb59434549592023-09-03T10:34:27ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062018-11-019610131910.21292/2075-1230-2018-96-10-13-191180Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitisE. V. Vаniev0A. G. Sаmoylovа1A. E. Ergeshov2O. V. Lovаchevа3I. A. Vаsilyevа4ФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» МЗ РФФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» МЗ РФФГБНУ «Центральный НИИ туберкулеза»ФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» МЗ РФФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» МЗ РФThe objective of the study: to assess the efficiency of therapeutic discrete automated plasmapheresis in the management of hepatotoxic reactions, developed in tuberculosis patients with multiple and extensive drug resistance, including those with concurrent viral hepatitis.Subjects and methods. 136 patients suffering from respiratory tuberculosis with multiple and extensive drug resistance were enrolled in the study. 56 of them had viral hepatitis: 3 (5.4%) patients suffered from hepatitis B, 49 (87.5%) from hepatitis С and 4 (7.1%) had both hepatitis В + С. After the initiation of chemotherapy, out of 56 patients with viral hepatitis, 36 (64.3%) developed hepatotoxic reactions which was statistically significantly more frequent versus 23 (28.8%) patients out of 80 ones without viral hepatitis, p < 0.01. Patients with hepatotoxic reactions were randomly divided into two groups (29 and 30 patients), and plasmapheresis was used to manage drug-induced liver disorders in one of them. Results. This method was used in 29 patients and it allowed managing hepatotoxic reactions without cancellation of chemotherapy. In the group where no plasmapheresis was used, chemotherapy was temporarily discontinued in 12 (40.0%) out of 30 patients from 6 to 20 days.https://www.tibl-journal.com/jour/article/view/1180аппаратный плазмаферезгапатотоксические реакциилекарственное поражение печенитуберкулезмножественная лекарственная устойчивостьширокая лекарственная устойчивостьвирусные гепатиты
spellingShingle E. V. Vаniev
A. G. Sаmoylovа
A. E. Ergeshov
O. V. Lovаchevа
I. A. Vаsilyevа
Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
Туберкулез и болезни лёгких
аппаратный плазмаферез
гапатотоксические реакции
лекарственное поражение печени
туберкулез
множественная лекарственная устойчивость
широкая лекарственная устойчивость
вирусные гепатиты
title Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
title_full Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
title_fullStr Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
title_full_unstemmed Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
title_short Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
title_sort automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
topic аппаратный плазмаферез
гапатотоксические реакции
лекарственное поражение печени
туберкулез
множественная лекарственная устойчивость
широкая лекарственная устойчивость
вирусные гепатиты
url https://www.tibl-journal.com/jour/article/view/1180
work_keys_str_mv AT evvaniev automatedplasmapheresisformanagementofhepatotoxicreactionstochemotherapyinpulmonarytuberculosispatientswithmultipledrugresistanceincludingthosewithconcurrentviralhepatitis
AT agsamoylova automatedplasmapheresisformanagementofhepatotoxicreactionstochemotherapyinpulmonarytuberculosispatientswithmultipledrugresistanceincludingthosewithconcurrentviralhepatitis
AT aeergeshov automatedplasmapheresisformanagementofhepatotoxicreactionstochemotherapyinpulmonarytuberculosispatientswithmultipledrugresistanceincludingthosewithconcurrentviralhepatitis
AT ovlovacheva automatedplasmapheresisformanagementofhepatotoxicreactionstochemotherapyinpulmonarytuberculosispatientswithmultipledrugresistanceincludingthosewithconcurrentviralhepatitis
AT iavasilyeva automatedplasmapheresisformanagementofhepatotoxicreactionstochemotherapyinpulmonarytuberculosispatientswithmultipledrugresistanceincludingthosewithconcurrentviralhepatitis